PHARMACIST COMPOUNDING AGAIN IN DANGER ON CAPITOL HILL

Published Online: Tuesday, May 1, 2007

State pharmacy boards could lose their authority to regulate pharmacist compounding activities under a controversial new legislative plan being hammered out on Capitol Hill. The proposal, still in draft form at press time, was being circulated by a bipartisan group of senators headed by Senate Committee on Health, Education, Labor, and Pensions Chairman Edward Kennedy (D, Mass).

Under the plan, responsibility for regulating drug compounding would shift to the FDA—an agency that has shown little appreciation for the traditional right of pharmacists to compound medicines. The National Community Pharmacists Association and several other national and state pharmacy groups are urging federal lawmakers to reject this legislative proposal and support pharmacy's long-standing authority to compound drugs.

Visit ePharmacy Times at www.pharmacytimes.com/articleNewsletter.cfm?ID=4503 for a related article about the pharmacy organizations'concerns.




Latest Articles
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Poor medication adherence is responsible for unnecessary illness, hospitalizations, disability, and premature death, particularly among patients with chronic diseases.
Police and a CVS pharmacy are on the lookout for a man who stole several boxes of diabetic test strips.
The FDA has approved Merck’s supplemental new drug application for single-dose fosaprepitant dimeglumine for injection.
Latest Issues
$auto_registration$
VSEO N/A